Milestone Investment Advisors LLC Raises Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Milestone Investment Advisors LLC boosted its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,890 shares of the financial services provider’s stock after purchasing an additional 160 shares during the quarter. Milestone Investment Advisors LLC’s holdings in iShares Biotechnology ETF were worth $911,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Raymond James Financial Inc. bought a new position in iShares Biotechnology ETF in the 4th quarter worth about $55,010,000. Aprio Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter worth about $18,476,000. Generali Investments CEE investicni spolecnost a.s. bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth approximately $11,370,000. Independent Advisor Alliance purchased a new stake in shares of iShares Biotechnology ETF during the fourth quarter valued at approximately $6,769,000. Finally, Wellington Shields Capital Management LLC increased its position in shares of iShares Biotechnology ETF by 1,753.4% during the fourth quarter. Wellington Shields Capital Management LLC now owns 39,663 shares of the financial services provider’s stock valued at $5,244,000 after acquiring an additional 37,523 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.9 %

IBB stock opened at $126.79 on Thursday. The stock’s 50 day simple moving average is $135.64 and its 200 day simple moving average is $138.50. iShares Biotechnology ETF has a 12-month low of $123.21 and a 12-month high of $150.57. The stock has a market capitalization of $5.99 billion, a PE ratio of 27.83 and a beta of 0.84.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, March 21st. Stockholders of record on Tuesday, March 18th were paid a $0.1212 dividend. The ex-dividend date of this dividend was Tuesday, March 18th. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.